Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB\TRAMETINIB vs DALTEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB\TRAMETINIB vs DALTEPARIN: Safety Overview

Metric DABRAFENIB\TRAMETINIB DALTEPARIN
Total FAERS Reports 113 3,570
Deaths Reported 10 789
Death Rate 8.8% 22.1%
Hospitalizations 17 1,443
Average Patient Age 55.1 yrs 67.7 yrs
% Female Patients 49.5% 39.7%
FDA Approval Date N/A Apr 4, 2002
Manufacturer N/A Pfizer Laboratories Div Pfizer Inc
Route N/A SUBCUTANEOUS
Marketing Status N/A Prescription